Drug intelligence / Profile preview

Multivitamin Injection

Development stage: Unknown
Lead developer: Martin & Brown Biosciences
Modality: Small Molecules
Administration: Parenteral, Injection

Overview

Multivitamin Injection is a parenteral nutritional supplement manufactured by Martin & Brown Biosciences. It contains a combination of essential vitamins, including Vitamin A, D3, E, C, and B-complex vitamins (B1, B2, B6, Niacinamide, and D-Panthenol). The product is indicated for the treatment and prevention of vitamin deficiencies in clinical settings where oral supplementation is inadequate or not possible. It supports various physiological functions, including metabolism, immune system strength, and proper growth. The injection is administered by healthcare professionals via the parenteral route.

Brand names: Multivitamin Injection

Targets

VDR (Vitamin D receptor)RAR (Retinoic acid receptor)

Beyond the preview

Go deeper on Multivitamin Injection.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multivitamin Injection.

Explore the full profile